KBP Biosciences Email Format
Pharmaceutical ManufacturingNew Jersey, United States11-50 Employees
KBP Biosciences is a clinical-stage pharmaceutical company focused on research, development, and potential commercialization of therapies across three primary areas: lung, heart, and kidney disease. Its discovery and development teams collaborate closely to build a pipeline that includes both clinical and pre-clinical candidates, with research groups addressing organ-specific disease progression, antimicrobial evaluation, and immunology-related mechanisms. The organization leverages a proprietary microbial bank and in vitro and in vivo models to characterize drug activity and mechanisms, aiming to identify new therapeutic directions and targets. Based in Princeton, New Jersey, KBP Biosciences operates with a focus on translating insights in immunology, infectious disease, and organ-specific science into innovative treatments. The company emphasizes patient care as a central objective and has engaged in notable strategic actions and leadership appointments over the years. A recent development noted in industry coverage references the firm’s past collaboration and asset-related activities involving a major pharmaceutical partner.